Health care companies in the United States by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Centene has the lowest figure of the 125 health care companies in the United States ranked by P/S ratio, at 0.2, followed by Cencora (0.2) and Molina Healthcare (0.2). Figures as of 21 Nov 2026, 06:50 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 125
- Lowest
- Centene0.2
- Median
- 4.7
- Combined market value
- ZAR 128.39T
- Countries
- 1
- Not ranked
- 15no P/S ratio on file
Market values as of .
United States▾
Health Care▾
All categories▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | CenteneCNC · Health Care | 0.2 | ZAR 555.3B | ZAR 1,121.62 | 2.74% down | 80% up | ||
| 2 | CencoraCOR · Health Care | 0.2 | ZAR 1.14T | ZAR 5,963.17 | 0.63% down | 7% down | ||
| 3 | Molina HealthcareMOH · Health Care | 0.2 | ZAR 182.1B | ZAR 3,488.85 | 2.43% down | 44% up | ||
| 4 | Cardinal HealthCAH · Health Care | 0.2 | ZAR 1.11T | ZAR 4,797.58 | 0.17% up | 30% up | ||
| 5 | CVS HealthCVS · Health Care | 0.3 | ZAR 1.82T | ZAR 1,421.64 | 1.00% up | 3% up | ||
| 6 | Cigna GroupCI · Health Care | 0.3 | ZAR 1.26T | ZAR 4,763.99 | 0.78% down | 2% down | ||
| 7 | McKessonMCK · Health Care | 0.3 | ZAR 2.17T | ZAR 18,806.78 | 0.68% up | 23% up | ||
| 8 | HumanaHUM · Health Care | 0.4 | ZAR 823.7B | ZAR 6,858.46 | 2.63% up | 67% up | ||
| 9 | Elevance HealthELV · Health Care | 0.4 | ZAR 1.5T | ZAR 6,937.25 | 1.11% up | 21% up | ||
| 10 | Universal Health ServicesUHS · Health Care | 0.6 | ZAR 181.9B | ZAR 3,155.42 | 2.54% up | 25% down | ||
| 11 | Oscar HealthOSCR · Health Care | 0.7 | ZAR 135.1B | ZAR 434.90 | 5.50% down | 94% up | ||
| 12 | UnitedHealth GroupUNH · Health Care | 0.7 | ZAR 5.36T | ZAR 5,976.53 | 2.84% up | 3% up | ||
| 13 | Henry ScheinHSIC · Health Care | 0.7 | ZAR 162.4B | ZAR 1,468.77 | 1.51% down | 16% up | ||
| 14 | DaVitaDVA · Health Care | 0.7 | ZAR 178.1B | ZAR 2,831.84 | 3.00% up | 30% up | ||
| 15 | Option Care HealthOPCH · Health Care | 0.8 | ZAR 83.2B | ZAR 555.54 | 0.06% down | 7% up | ||
| 16 | BrightSpring Health ServicesBTSG · Health Care | 1.0 | ZAR 220.1B | ZAR 1,105.97 | 1.77% down | 85% up | ||
| 17 | Tenet HealthcareTHC · Health Care | 1.0 | ZAR 368.4B | ZAR 4,628.41 | 0.15% down | 37% up | ||
| 18 | Baxter InternationalBAX · Health Care | 1.2 | ZAR 231B | ZAR 446.50 | 0.00% | 39% up | ||
| 19 | PACS GroupPACS · Health Care | 1.3 | ZAR 121.9B | ZAR 767.97 | 1.49% up | 56% up | ||
| 20 | HCA HealthcareHCA · Health Care | 1.3 | ZAR 1.75T | ZAR 8,363.28 | 3.31% up | 6% down | ||
| 21 | MiniMed GroupMMED · Health Care | 1.5 | ZAR 79.2B | ZAR 281.55 | 1.54% down | 12% down | ||
| 22 | Hims & Hers HealthHIMS · Health Care | 1.5 | ZAR 60.2B | ZAR 256.75 | 8.86% down | 54% down | ||
| 23 | AvantorAVTR · Health Care | 1.5 | ZAR 176.8B | ZAR 260.97 | 1.85% down | 31% up | ||
| 24 | ViatrisVTRS · Health Care | 1.6 | ZAR 395.8B | ZAR 345.21 | 1.26% down | 90% up | ||
| 25 | MedlineMDLN · Health Care | 1.7 | ZAR 857.2B | ZAR 651.38 | 2.11% down | 8% down | ||
| 26 | SolventumSOLV · Health Care | 1.7 | ZAR 252.6B | ZAR 1,486.00 | 1.52% down | 3% up | ||
| 27 | GE HealthCare TechnologiesGEHC · Health Care | 1.8 | ZAR 641.2B | ZAR 1,418.12 | 1.53% down | 7% up | ||
| 28 | Ensign GroupENSG · Health Care | 2.0 | ZAR 180.9B | ZAR 3,100.73 | 0.15% down | 5% down | ||
| 29 | Labcorp HoldingsLH · Health Care | 2.1 | ZAR 524.2B | ZAR 6,456.27 | 0.47% down | 39% up | ||
| 30 | Encompass HealthEHC · Health Care | 2.2 | ZAR 230.6B | ZAR 2,350.34 | 1.04% up | 16% up | ||
| 31 | Zimmer Biomet HoldingsZBH · Health Care | 2.3 | ZAR 336.5B | ZAR 1,777.92 | 0.36% down | 10% up | ||
| 32 | Concentra Group Holdings ParentCON · Health Care | 2.4 | ZAR 92.5B | ZAR 735.79 | 0.94% up | 105% up | ||
| 33 | Amneal PharmaceuticalsAMRX · Health Care | 2.4 | ZAR 129.4B | ZAR 371.41 | 1.26% down | 79% up | ||
| 34 | IQVIA HoldingsIQV · Health Care | 2.5 | ZAR 712.4B | ZAR 4,322.94 | 1.89% down | 11% up | ||
| 35 | Bristol-Myers SquibbBMY · Health Care | 2.5 | ZAR 2.11T | ZAR 1,034.05 | 0.79% up | 26% up | ||
| 36 | PfizerPFE · Health Care | 2.5 | ZAR 2.75T | ZAR 481.85 | 0.51% down | 10% up | ||
| 37 | BrukerBRKR · Health Care | 2.5 | ZAR 151.6B | ZAR 992.89 | 9.08% down | 31% up | ||
| 38 | Quest DiagnosticsDGX · Health Care | 2.6 | ZAR 499.7B | ZAR 4,542.06 | 0.31% down | 35% up | ||
| 39 | Becton, DickinsonBDX · Health Care | 2.7 | ZAR 1.02T | ZAR 3,741.91 | 0.05% up | 40% up | ||
| 40 | RadNetRDNT · Health Care | 2.7 | ZAR 96.6B | ZAR 1,225.91 | 0.29% up | 16% down | ||
| 41 | Align TechnologyALGN · Health Care | 2.7 | ZAR 192.3B | ZAR 2,728.79 | 2.82% down | 12% up | ||
| 42 | PTC TherapeuticsPTCT · Health Care | 2.7 | ZAR 82.9B | ZAR 992.19 | 3.27% down | 26% down | ||
| 43 | Elanco Animal HealthELAN · Health Care | 2.7 | ZAR 226.3B | ZAR 452.66 | 2.09% down | 18% up | ||
| 44 | Cooper CompaniesCOO · Health Care | 2.7 | ZAR 196.9B | ZAR 1,035.45 | 2.40% down | 20% down | ||
| 45 | ChemedCHE · Health Care | 2.8 | ZAR 125B | ZAR 9,647.39 | 0.50% down | 25% up | ||
| 46 | Legend BiotechLEGN · Health Care | 2.9 | ZAR 52B | ZAR 268.18 | 5.28% down | 43% down | ||
| 47 | Globus MedicalGMED · Health Care | 3.0 | ZAR 155.8B | ZAR 1,176.31 | 2.49% down | 20% down | ||
| 48 | Boston ScientificBSX · Health Care | 3.0 | ZAR 1.07T | ZAR 738.25 | 2.35% down | 56% down | ||
| 49 | TeleflexTFX · Health Care | 3.2 | ZAR 112.7B | ZAR 2,841.51 | 1.11% down | 48% up | ||
| 50 | Merit Medical SystemsMMSI · Health Care | 3.3 | ZAR 88.9B | ZAR 1,483.19 | 0.08% down | 3% down | ||
| 51 | ZoetisZTS · Health Care | 3.4 | ZAR 565.3B | ZAR 1,391.21 | 2.08% down | 34% down | ||
| 52 | InsuletPODD · Health Care | 3.4 | ZAR 162.5B | ZAR 2,341.90 | 2.96% down | 59% down | ||
| 53 | MSA SafetyMSA · Health Care | 3.5 | ZAR 115.2B | ZAR 2,990.11 | 3.52% down | 13% up | ||
| 54 | BioMarin PharmaceuticalBMRN · Health Care | 3.6 | ZAR 205.8B | ZAR 1,062.36 | 1.64% down | 12% up | ||
| 55 | LifeStance Health GroupLFST · Health Care | 3.7 | ZAR 92.4B | ZAR 243.04 | 3.60% up | 107% up | ||
| 56 | BiogenBIIB · Health Care | 3.7 | ZAR 648.8B | ZAR 4,389.24 | 1.00% up | 41% up | ||
| 57 | Bio-Rad LaboratoriesBIO · Health Care | 3.7 | ZAR 169.7B | ZAR 6,311.54 | 2.34% down | 16% up | ||
| 58 | Charles River Laboratories InternationalCRL · Health Care | 3.8 | ZAR 264.9B | ZAR 5,527.57 | 4.15% down | 96% up | ||
| 59 | Abbott LaboratoriesABT · Health Care | 4.0 | ZAR 3.14T | ZAR 1,811.34 | 0.84% down | 19% down | ||
| 60 | HaemoneticsHAE · Health Care | 4.1 | ZAR 96.2B | ZAR 2,113.11 | 0.17% down | 53% up | ||
| 61 | Lantheus HoldingsLNTH · Health Care | 4.3 | ZAR 117.4B | ZAR 1,795.51 | 0.00% | 83% up | ||
| 62 | IncyteINCY · Health Care | 4.5 | ZAR 410.9B | ZAR 2,015.77 | 1.07% down | 14% up | ||
| 63 | Ionis PharmaceuticalsIONS · Health Care | 4.7 | ZAR 77.8B | ZAR 467.43 | 2.35% down | 64% down | ||
| 64 | StrykerSYK · Health Care | 4.7 | ZAR 2.08T | ZAR 5,451.60 | 0.98% down | 15% down | ||
| 65 | Merck & CoMRK · Health Care | 5.1 | ZAR 5.8T | ZAR 2,351.57 | 0.69% up | 36% up | ||
| 66 | Alnylam PharmaceuticalsALNY · Health Care | 5.2 | ZAR 338.8B | ZAR 2,529.19 | 2.71% down | 66% down | ||
| 67 | Neurocrine BiosciencesNBIX · Health Care | 5.3 | ZAR 268B | ZAR 2,647.89 | 3.84% down | 10% up | ||
| 68 | Thermo Fisher ScientificTMO · Health Care | 5.6 | ZAR 4.36T | ZAR 11,774.40 | 2.79% down | 17% up | ||
| 69 | RevvityRVTY · Health Care | 5.7 | ZAR 285.1B | ZAR 2,553.81 | 4.20% down | 54% up | ||
| 70 | ResMedRMD · Health Care | 5.9 | ZAR 582.8B | ZAR 4,143.74 | 0.53% down | 6% down | ||
| 71 | HealthEquityHQY · Health Care | 6.0 | ZAR 137.8B | ZAR 1,666.25 | 2.70% down | 4% down | ||
| 72 | Caris Life SciencesCAI · Health Care | 6.2 | ZAR 88.7B | ZAR 309.16 | 5.18% down | 23% down | ||
| 73 | DanaherDHR · Health Care | 6.3 | ZAR 2.73T | ZAR 3,875.21 | 3.16% down | 0% up | ||
| 74 | DexComDXCM · Health Care | 6.3 | ZAR 520.2B | ZAR 1,394.91 | 1.08% down | 33% up | ||
| 75 | AmgenAMGN · Health Care | 6.4 | ZAR 4.14T | ZAR 7,661.08 | 0.15% down | 30% up | ||
| 76 | Regeneron PharmaceuticalsREGN · Health Care | 6.6 | ZAR 1.67T | ZAR 16,191.07 | 0.19% down | 22% up | ||
| 77 | IlluminaILMN · Health Care | 6.7 | ZAR 512.7B | ZAR 3,390.89 | 3.90% down | 62% up | ||
| 78 | Medpace HoldingsMEDP · Health Care | 6.7 | ZAR 300.3B | ZAR 10,736.83 | 3.70% down | 7% up | ||
| 79 | ExelixisEXEL · Health Care | 6.8 | ZAR 277.3B | ZAR 1,136.57 | 1.82% down | 55% up | ||
| 80 | Johnson & JohnsonJNJ · Health Care | 6.9 | ZAR 11.45T | ZAR 4,756.43 | 1.25% up | 31% up | ||
| 81 | Agilent TechnologiesA · Health Care | 6.9 | ZAR 844.8B | ZAR 2,996.27 | 2.83% down | 16% up | ||
| 82 | Gilead SciencesGILD · Health Care | 7.0 | ZAR 3.63T | ZAR 2,926.80 | 0.06% down | 31% up | ||
| 83 | United TherapeuticsUTHR · Health Care | 7.4 | ZAR 415.5B | ZAR 9,755.37 | 0.78% down | 18% up | ||
| 84 | Halozyme TherapeuticsHALO · Health Care | 7.5 | ZAR 183.2B | ZAR 1,606.46 | 1.82% down | 32% up | ||
| 85 | Mettler-Toledo InternationalMTD · Health Care | 8.2 | ZAR 583.1B | ZAR 29,313.42 | 2.27% down | 17% up | ||
| 86 | AbbVieABBV · Health Care | 8.3 | ZAR 8.9T | ZAR 5,033.06 | 0.94% up | 20% up | ||
| 87 | West Pharmaceutical ServicesWST · Health Care | 8.8 | ZAR 478.1B | ZAR 6,863.74 | 1.61% down | 46% up | ||
| 88 | PenumbraPEN · Health Care | 9.0 | ZAR 221.2B | ZAR 5,611.98 | 0.28% down | 11% up | ||
| 89 | Corcept TherapeuticsCORT · Health Care | 9.1 | ZAR 122.4B | ZAR 1,118.81 | 2.09% down | 16% down | ||
| 90 | Madrigal PharmaceuticalsMDGL · Health Care | 9.2 | ZAR 154.9B | ZAR 6,666.78 | 4.45% down | 28% down | ||
| 91 | Travere TherapeuticsTVTX · Health Care | 9.2 | ZAR 79.3B | ZAR 826.53 | 2.69% down | 39% up | ||
| 92 | Bio-TechneTECH · Health Care | 9.4 | ZAR 200.8B | ZAR 1,277.96 | 0.04% down | 18% up | ||
| 93 | Edwards LifesciencesEW · Health Care | 9.7 | ZAR 1.03T | ZAR 1,791.11 | 1.95% down | 22% up | ||
| 94 | 10x GenomicsTXG · Health Care | 10.6 | ZAR 119.8B | ZAR 910.94 | 9.72% down | 213% up | ||
| 95 | Axsome TherapeuticsAXSM · Health Care | 10.7 | ZAR 119.7B | ZAR 2,274.90 | 4.66% down | 9% down | ||
| 96 | Vertex PharmaceuticalsVRTX · Health Care | 10.9 | ZAR 2.3T | ZAR 9,057.04 | 1.08% down | 22% up | ||
| 97 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | ZAR 110.4B | ZAR 1,690.52 | 0.65% up | 35% up | ||
| 98 | IDEXX LaboratoriesIDXX · Health Care | 12.4 | ZAR 936.9B | ZAR 11,891.69 | 1.95% down | 5% down | ||
| 99 | Arrowhead PharmaceuticalsARWR · Health Care | 13.0 | ZAR 102.8B | ZAR 727.52 | 5.22% down | 8% up | ||
| 100 | Intuitive SurgicalISRG · Health Care | 13.7 | ZAR 2.43T | ZAR 7,017.61 | 2.01% down | 27% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 17.5858 ZAR). 15 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies in the United States have the lowest P/S ratio?
Centene (0.2), Cencora (0.2) and Molina Healthcare (0.2) have the lowest P/S ratio of the 125 health care companies in the United States ranked here as of 21 Nov 2026, 06:50 UTC.
How many health care companies in the United States are in this ranking?
125 are ranked by P/S ratio. 15 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies in the United States worth together?
The 125 health care companies in the United States ranked by P/S ratio have a combined market value of ZAR 128.39T as of 21 Nov 2026, 06:50 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies in the United States by P/S ratio”, data as of 21 November 2026. https://funkfolio.com/companies/sector/health-care?country=united-states&by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.